A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MA / mefenamic acid

[Related PubMed/MEDLINE]
Total Number of Papers: 47
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MA  (>> Co-occurring Abbreviation)
Long Form:   mefenamic acid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m6A abrogation in RNA. AKI, FTO
2019 Multicomponent Crystal of Mefenamic Acid and N-Methyl-d-Glucamine: Crystal Structures and Dissolution Study. MC, MG
2019 Rat palatability, pharmacodynamics effect and bioavailability of mefenamic acid formulations utilizing hot-melt extrusion technology. SDs
2018 Salts of Mefenamic Acid With Amines: Structure, Thermal Stability, Desolvation, and Solubility. EDM, MOP, MP, TA
2017 Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation. ---
2017 In Vitro and In Vivo Evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions. CS, SDs
2017 Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. DSC, FFA, FTIR, MW, PEG 4000, PXRD, SDs, SEM, TGA
2017 Investigation of the combined effect of MgO and PEG on the release profile of mefenamic acid prepared via hot-melt extrusion techniques. MgO, PEG
2016 Assessment of in vitro antiovulatory activities of nonsteroidal anti-inflammatory drugs and comparison with in vivo reproductive toxicities of medaka (Oryzias latipes). ASA, DCF, GSI, KP, NSAIDs, SA
10  2016 Solvates of selected fenamic acids with substituted pyridines: structure, thermal stability and desolvation. 2PIC, 3CLPYR, 3PIC, 4-pic, TFA
11  2015 Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. FTO, NRL
12  2015 Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology. DSC, HME, ODTs
13  2015 Occurrence and risk assessment of pharmaceuticals and personal care products and endocrine disrupting chemicals in reclaimed water and receiving groundwater in China. BPA, EDCs, KP, NA, PPCPs, RQs, SP
14  2015 Preparation and investigation of mefenamic acid - polyethylene glycol - sucrose ester solid dispersions. NSAID
15  2014 Comparison of the effects of Matricaria chamomila (Chamomile) extract and mefenamic acid on the intensity of premenstrual syndrome. PMS
16  2014 Formulation and evaluation of suspensions: mefenamic acid prodrugs. IR
17  2014 Formulation and evaluation of time-controlled triple-concentric mefenamic acid tablets for rheumatoid arthritis. ---
18  2014 Inflammation targeted Gd(3+)-based MRI contrast agents imaging tumor and rheumatoid arthritis models. AIA, CAs, CNR, IEs, NSAID
19  2014 Molecular basis of crystal morphology-dependent adhesion behavior of mefenamic acid during tableting. AFM
20  2014 Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. ---
21  2013 Formulation and evaluation of mefenamic acid sustained release matrix pellets. MCC, MTR, PVP
22  2013 Furoic and mefenamic acids as new matrices for matrix assisted laser desorption/ionization-(MALDI)-mass spectrometry. MALDI-MS, UV
23  2013 Synthesis, kinetics and pharmacological evaluation of mefenamic acid mutual prodrug. MA-P
24  2012 A novel tool for the prediction of tablet sticking during high speed compaction. ---
25  2012 Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies. SAs
26  2011 Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers. CAP, DSC, EC, MESE, SEM, SLS, XRD
27  2011 Ultra-fast catalytic reduction of dyes by ionic liquid recoverable and reusable mefenamic acid derived gold nanoparticles. EB, FTIR, MB, RB, SEM, TEM
28  2010 Tyrosine and glycine derivatives as potential prodrugs: design, synthesis, and pharmacological evaluation of amide derivatives of mefenamic acid. ---
29  2009 Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions. Hyper-DSC, PXRD, SD
30  2009 Studies on mefenamic acid microparticles: formulation, in vitro release, and in situ studies in rats. ---
31  2008 A comparative histological study of alginate beads as a promising controlled release delivery for mefenamic acid. NSAI
32  2008 An anti-inflammatory drug (mefenamic acid) incorporated in biodegradable alginate beads: development and optimization of the process using factorial design. ---
33  2008 Concomitant polymorphism in confined environment. SAMs
34  2008 Influence of loading volume of mefenamic acid on granules and tablet characteristics using a compaction simulator. ---
35  2007 Influence of loading volume of mefenamic acid on granules and tablet characteristics using a compaction simulator. ---
36  2007 Sodium mefenamate as a solution for the formulation and dissolution problems of mefenamic acid. DSC, FTIR
37  2006 Role for prostaglandins in the regulation of type 1 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. 11beta-HSD, hGL, PG
38  2004 Solid-state characterization of mefenamic acid. DSC, FTIR, IDR, pXRD
39  2003 Interaction between nitric oxide and prostanoids in arterioles of rat cremaster muscle in vivo. l-NNA, NO
40  2003 Investigations on mefenamic acid sustained release tablets with water-insoluble gel. CaGL
41  2002 The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. EL, IPM, ISDN
42  2000 Preparation of mefenamic acid sustained release beads based on kappa-carrageenan. TTD
43  1997 Urinary excretion of mefenamic acid and its metabolites including their esterglucuronides in preterm infants undergoing mefenamic acid therapy. ---
44  1994 Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. tmax
45  1994 Role of nitric oxide and prostaglandins in the regulation of diaphragmatic arteriolar tone in the rat. ACh, L-NNA, NO
46  1992 Rapid and sensitive liquid chromatographic assay of mefenamic acid in plasma. ---
47  1992 Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin. PDA